Följ
Akshay Desai
Akshay Desai
Assistant Professor of Medicine, Harvard Medical School
Verifierad e-postadress på partners.org
Titel
Citeras av
Citeras av
År
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
54985*2017
Angiotensin–neprilysin inhibition versus enalapril in heart failure
JJV McMurray, M Packer, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ...
New England Journal of Medicine 371 (11), 993-1004, 2014
66872014
Dapagliflozin in patients with heart failure and reduced ejection fraction
JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ...
New England Journal of Medicine 381 (21), 1995-2008, 2019
55312019
Spironolactone for heart failure with preserved ejection fraction
B Pitt, MA Pfeffer, SF Assmann, R Boineau, IS Anand, B Claggett, ...
New England Journal of Medicine 370 (15), 1383-1392, 2014
25632014
Strategies for multivessel revascularization in patients with diabetes
ME Farkouh, M Domanski, LA Sleeper, FS Siami, G Dangas, M Mack, ...
New England journal of medicine 367 (25), 2375-2384, 2012
21242012
Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction
SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ...
New England Journal of Medicine 381 (17), 1609-1620, 2019
17702019
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
HH Parving, BM Brenner, JJV McMurray, D De Zeeuw, SM Haffner, ...
New England Journal of Medicine 367 (23), 2204-2213, 2012
16142012
Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction
SD Solomon, JJV McMurray, B Claggett, RA de Boer, D DeMets, ...
New England Journal of Medicine 387 (12), 1089-1098, 2022
11282022
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial
MA Pfeffer, B Claggett, SF Assmann, R Boineau, IS Anand, N Clausell, ...
Circulation 131 (1), 34-42, 2015
9292015
Rehospitalization for heart failure: predict or prevent?
AS Desai, LW Stevenson
Circulation 126 (4), 501-506, 2012
7832012
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure
M Packer, JJV McMurray, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ...
Circulation 131 (1), 54-61, 2015
7782015
Treatment of anemia with darbepoetin alfa in systolic heart failure
K Swedberg, JB Young, IS Anand, S Cheng, AS Desai, R Diaz, ...
New England Journal of Medicine 368 (13), 1210-1219, 2013
6482013
2017 cardiovascular and stroke endpoint definitions for clinical trials
KA Hicks, KW Mahaffey, R Mehran, SE Nissen, SD Wiviott, B Dunn, ...
Circulation 137 (9), 961-972, 2018
6052018
Effect of dapagliflozin on heart failure and mortality in type 2 diabetes mellitus
ET Kato, MG Silverman, O Mosenzon, TA Zelniker, A Cahn, RHM Furtado, ...
Circulation 139 (22), 2528-2536, 2019
6042019
Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials
AS Desai, JC Fang, WH Maisel, KL Baughman
Jama 292 (23), 2874-2879, 2004
5442004
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
SD Solomon, B Claggett, EF Lewis, A Desai, I Anand, NK Sweitzer, ...
European heart journal 37 (5), 455-462, 2016
5342016
Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not …
SM Dunlay, MM Givertz, D Aguilar, LA Allen, M Chan, AS Desai, A Deswal, ...
Circulation 140 (7), e294-e324, 2019
5312019
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin‐converting enzyme inhibition in patients with chronic systolic heart failure: rationale for …
JJV McMurray, M Packer, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ...
European journal of heart failure 15 (9), 1062-1073, 2013
5102013
Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction
VR Taqueti, SD Solomon, AM Shah, AS Desai, JD Groarke, MT Osborne, ...
European heart journal 39 (10), 840-849, 2018
4682018
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
AS Desai, JJV McMurray, M Packer, K Swedberg, JL Rouleau, F Chen, ...
European heart journal 36 (30), 1990-1997, 2015
4652015
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20